Search Results - "Simzer EM"

Alzheimer's Research UK Research Conference 2026.

Authors: Simzer EM Elliott JA Meftah S et al.

Source: Brain and neuroscience advances [Brain Neurosci Adv] 2026 Jun 11; Vol. 10, pp. 23982128261454415. Date of Electronic Publication: 2026 Jun 11 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: United States NLM ID: 101702599 Publication Model: eCollection Cited Medium: Internet ISSN: 2398-2128 (Electronic) Linking ISSN: 23982128 NLM ISO Abbreviation: Brain Neurosci Adv Subsets: PubMed not MEDLINE

Confirmation of p-tau Ser356's association with Alzheimer's disease pathology and lowering in response to WZ4003 treatment in brain slice cultures. Reply to: "Phospho-tau Ser356 is mostly confined to pre-NFT neurons in Alzheimer's pathology".

Authors: Taylor LW Simzer EM Young LFP et al.

Source: Acta neuropathologica [Acta Neuropathol] 2025 Dec 11; Vol. 150 (1), pp. 63. Date of Electronic Publication: 2025 Dec 11.

Publication Type: Letter

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE; In Process

Evidence for trans-synaptic propagation of oligomeric tau in human progressive supranuclear palsy.

Authors: McGeachan RI Keavey L Simzer EM et al.

Source: Nature neuroscience [Nat Neurosci] 2025 Aug; Vol. 28 (8), pp. 1622-1634. Date of Electronic Publication: 2025 Jul 16.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 9809671 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1726 (Electronic) Linking ISSN: 10976256 NLM ISO Abbreviation: Nat Neurosci Subsets: MEDLINE

Personalised regional modelling predicts tau progression in the human brain.

Authors: Chaggar, Pavanjit Vogel, Jacob Binette, Alexa Pichet et al.

Source: PLoS Biology. 7/21/2025, Vol. 23 Issue 7, p1-25. 25p.

Reduced synaptic vesicle protein 2A in extracellular vesicles and brains of Alzheimer's disease: associations with Aβ, tau, synaptic proteins and APOE ε4.

Authors: Nussbaumer, Jana Barve, Aatmika Zufferey, Valentin et al.

Source: Translational Neurodegeneration. 9/24/2025, Vol. 14 Issue 1, p1-20. 20p.

mRNA and circRNA mislocalization to synapses are key features of Alzheimer's disease.

Authors: Smukowski, Samuel N. Danyko, Cassidy Somberg, Jenna et al.

Source: PLoS Genetics. 7/29/2024, Vol. 20 Issue 7, p1-35. 35p.

Divergent disruptive effects of soluble recombinant tau assemblies on synaptic plasticity in vivo.

Authors: Yang, Yin Ondrejcak, Tomas Hu, Neng-Wei et al.

Source: Molecular Brain. 4/18/2025, Vol. 18 Issue 1, p1-14. 14p.

Single-molecule imaging of Tau reveals how phosphorylation affects its movement and confinement in living cells.

Authors: Padmanabhan, Pranesh Kneynsberg, Andrew Cruz, Esteban et al.

Source: Molecular Brain. 2/12/2024, Vol. 17 Issue 1, p1-5. 5p.

Striatal Tau Pathology Underlies Monoaminergic Disruption in Progressive Supranuclear Palsy.

Authors: Dong C Ma JH Qiao HW et al.

Source: Clinical nuclear medicine [Clin Nucl Med] 2026 Jul 06. Date of Electronic Publication: 2026 Jul 06.

Publication Type: Journal Article

Journal Info: Publisher: Lippincott Country of Publication: United States NLM ID: 7611109 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-0229 (Electronic) Linking ISSN: 03639762 NLM ISO Abbreviation: Clin Nucl Med Subsets: MEDLINE

Axonal tau reduction ameliorates tau and amyloid pathology in a mouse model of Alzheimer's disease.

Authors: Zare, Abdolhossein Salehi, Saeede Bader, Jakob M. et al.

Source: Translational Neurodegeneration. 7/29/2025, Vol. 14 Issue 1, p1-23. 23p.

Glial phagocytosis for synapse and toxic proteins in neurodegenerative diseases.

Authors: Choi, Yeseong Chung, Won-Suk

Source: Molecular Neurodegeneration. 7/9/2025, Vol. 20 Issue 1, p1-23. 23p.

Extracellular vesicles in TDP-43 proteinopathies: pathogenesis and biomarker potential.

Authors: Dellar, Elizabeth R. Nikel, Lara Fowler, Stephanie et al.

Source: Molecular Neurodegeneration. 6/10/2025, Vol. 20 Issue 1, p1-21. 21p.

Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer's disease continuum.

Authors: Goossens, Julie Cervantes González, Alba Dewit, Nele et al.

Source: Alzheimer's Research & Therapy. 10/28/2023, Vol. 15 Issue 1, p1-13. 13p.

Novel strategies for targeting tau oligomers in neurodegenerative diseases.

Authors: Lin J Li H Jiang L et al.

Source: Journal of neurology [J Neurol] 2025 May 08; Vol. 272 (6), pp. 383. Date of Electronic Publication: 2025 May 08.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE

Improving effects of melatonin on memory and synaptic potentiation in a mouse model of Alzheimer's-like disease: the involvement of glutamate homeostasis and mGluRs receptors.

Authors: Shabani Sadr, Narjes Khatoun Bakhtiarzadeh, Fatemeh Shahpasand, Koorosh et al.

Source: Behavioral & Brain Functions. 3/18/2025, Vol. 21 Issue 1, p1-21. 21p.

Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer's disease.

Authors: Davis, Miyah R. Robinson, Edward Koronyo, Yosef et al.

Source: Acta Neuropathologica Communications. 2/15/2025, Vol. 13 Issue 1, p1-23. 23p.

TNMD BRICHOS domain attenuates tau pathology and memory deficits in a mouse model of tauopathy.

Authors: Su D Li H Pan L et al.

Source: Cell death & disease [Cell Death Dis] 2026 Apr 24; Vol. 17 (1). Date of Electronic Publication: 2026 Apr 24.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE

Timing matters: early administration of a high-affinity antibody targeting the tau repeat domain prevents aggregation in a mouse tauopathy model.

Authors: Penny LK Arastoo M Lofthouse R et al.

Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2026 Feb 14; Vol. 18 (1). Date of Electronic Publication: 2026 Feb 14.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium: Internet ISSN: 1758-9193 (Electronic) NLM ISO Abbreviation: Alzheimers Res Ther Subsets: MEDLINE

Aqueous extractable nonfibrillar and sarkosyl extractable fibrillar Alzheimer's disease tau seeds have distinct properties.

Authors: Mate de Gerando, Anastasie Khasnavis, Anita Welikovitch, Lindsay A. et al.

Source: Acta Neuropathologica Communications. 9/9/2024, Vol. 12 Issue 1, p1-17. 17p.

Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies.

Authors: Zhang, Xingyu Wang, Jiangyu Zhang, Zhentao et al.

Source: Translational Neurodegeneration. 8/6/2024, Vol. 13 Issue 1, p1-17. 17p.